K. Vidqvist

发表

Short interruptions of TNF-inhibitor treatment can be associated with treatment failure in patients with immune-mediated diseases

H. Mäkinen, T. Jokiranta, K. Aalto, 2022, Autoimmunity.

Progesterone receptor concentration differences in the chick oviduct cells and apparent down-regulation by ligand. A semiquantitative immunohistochemical study.

D. Toft, T. Joensuu, P. Tuohimaa, 1989, Journal of Steroid Biochemistry.

Tofacitinib treatment modulates the levels of several inflammation-related plasma proteins in rheumatoid arthritis and baseline levels of soluble biomarkers associate with the treatment response

M. Leirisalo-Repo, P. Isomäki, A. Kuuliala, 2022, Clinical and experimental immunology.

Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis

T. Jokiranta, J. Rutanen, M. Leirisalo-Repo, 2021, Rheumatology International.

The activity of JAK-STAT pathways in rheumatoid arthritis: constitutive activation of STAT3 correlates with interleukin 6 levels.

O. Silvennoinen, P. Isomäki, M. Korpela, 2015, Rheumatology.

Disease activity of idiopathic juvenile arthritis continues through adolescence despite the use of biologic therapies.

M. Korpela, M. Malin, K. Vidqvist, 2013, Rheumatology.